Premium Only Content

Robert Stone & Dr. Marcel van den Brink - City of Hope - Innovative, Compassionate Accessible Care
Robert Stone is the CEO of City of Hope ( https://www.cityofhope.org/robert-stone ), a premier cancer research and treatment center dedicated to innovation in biomedical science and the delivery of compassionate, world-class patient care. A seasoned health care executive, he has served in a number of strategic decision-making roles since he joined City of Hope in 1996, culminating with his appointment as president in 2012, CEO in 2014, and as the Helen and Morgan Chu Chief Executive Officer Distinguished Chair in 2021.
Mr. Stone has J.D., University of Chicago Law School, Chicago, IL.
Mr. Stone’s strategic acumen, empathy and visionary leadership have driven City of Hope’s rapid evolution.
As an independent institution dedicated to advancing the fight against cancer and diabetes, City of Hope is accelerating opportunities for high-impact discovery and ensuring that patients around the world have access to the most advanced therapies. Recent examples include a groundbreaking alliance in precision medicine with the Translational Genomics Research Institute (TGen), a leader in genomic analysis and bioinformatics; leadership in CAR T cell therapy research and therapy; and an innovative program to offer cancer support services to the employees of some of American’s largest employers, regardless of geography.
In the last few years, City of Hope has expanded access to its exceptional, patient-centered care, growing from a single site outside of Los Angeles to a clinical network spanning dozens of locations throughout the United States.
Mr. Stone recently was named Hospital CEO of the Year by the Los Angeles Business Journal and has been listed in the Los Angeles Business Journal's Top 500 for five years. He was elected to the Healthcare Leadership Council, a nationwide policy advocacy organization, in 2017.
Dr. Marcel van den Brink, M.D., Ph.D.( https://www.cityofhope.org/marcel-van-den-brink ), is President of City of Hope Cancer Center, main campus in Los Angeles, and National Medical Center, chief physician executive and the Deana and Steve Campbell Chief Physician Executive Distinguished Chair, and is a globally recognized leader in the basic and translational science of bone marrow transplantation (BMT), the microbiome and cancer immunotherapy. His specialties include immune reconstitution and graft-versus-host disease — side effects many BMT patients experience — as well as the impact of the microbiome on immunotherapy for cancer.
A researcher who has opened new fields of investigation and improved patient outcomes, Dr. Van den Brink has pursued innovative ways to improve and optimize BMT, developing strategies to make the process less toxic and lower the rate of recurrence. Throughout his career, he has maintained an intense focus on converting scientific discoveries in his laboratory into better therapies for patients around the world.
Dr. Van den Brink joined City of Hope in part because of their shared commitment to advancing the frontiers of cancer care and research. He is known for his inclusive approach to leadership and his devotion to providing junior faculty colleagues with mentorship and career development opportunities.
A recipient of numerous national and international awards, Dr. Van den Brink is a member of the Royal Netherlands Academy of Arts and Sciences. Among many leadership roles, he serves as vice chair of the board for Deutsche Knochenmark Stiftung, a global donor registration that facilitates 40% of all unrelated allogenic blood stem cell donations worldwide.
Before he joined City of Hope, Dr. Van den Brink served in leadership positions at Memorial Sloan Kettering Cancer Center for 24 years, most recently as the Alan N. Houghton Chair in Immunology and the head of the Division of Hematologic Malignancies.
Dr. Van den Brink has a Ph.D., Medicine (Immunology), and M.D., Cum Laude, University of Leiden, The Netherlands, completed a postdoctoral fellowship at the Pittsburgh Cancer Institute in Pittsburgh, PA and residency at Duke University Medical Center in Durham, NC.
Dr. van den Brink was a Clinical Fellow in Hematology and Oncology at Beth Israel Deaconess Medical Center and a Clinical Fellow in Medicine at Harvard Medical School in Boston, MA. He then carried out a post-doctoral fellowship at the Dana Farber Cancer Institute in Boston, MA from 1995 to 1999.
#Cancer #Oncology #CityOfHope #RobertStone #MarcelVanDenBrink #Microbiome #Immunotherapy #CarT #Thymus #ThymicInvolution #Regeneration #BoneMarrowTransplantation #TranslationalGenomicsResearchInstitute #PrecisionMedicine #GraftVersusHostDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #Research
-
LIVE
Vigilant News Network
7 hours agoUK Government BUSTED in Secret Plot to Extract Your Data | Media Blackout
1,381 watching -
1:03:32
Winston Marshall
3 days ago"War On Children!" The DEMISE Of The West Starts With Schools - Katharine Birbalsingh
83.4K62 -
48:02
Survive History
10 hours ago $2.28 earnedCould You Survive as a Sharpshooter in the Napoleonic Wars?
29.2K2 -
12:03
Space Ice
11 hours agoSteven Seagal's China Salesman - Mike Tyson Knocks Him Out - Worst Movie Ever
20.3K14 -
11:37
Degenerate Jay
10 hours ago $2.39 earnedJames Bond Needs Quality Over Quantity From Amazon
20.7K2 -
15:23
Misha Petrov
11 hours agoTrad Wives & Girl Bosses Go to WAR!
27.6K36 -
2:03:11
TheDozenPodcast
9 hours agoFootball villain fighting the state: Joey Barton
26.2K1 -
LIVE
Scottish Viking Gaming
12 hours ago💚Rumble :|: Sunday Funday :|: Smash the Blerps and Vape the Terpes
483 watching -
1:45:00
RG_GerkClan
13 hours ago🔴LIVE Sunday Special - It's Time for World Domination - Civilization VII - Gerk Clan
71.9K27 -
LIVE
Major League Fishing
4 days agoLIVE Tackle Warehouse Invitationals, Stop 1, Day 3
138 watching